Clinical Trial Update: Effects of Normobaric Hypoxic Training in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]

View source ↗

Summary

A clinical trial update describes a study evaluating normobaric hypoxic training for metabolic dysfunction-associated steatotic liver disease (MASLD), with the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: University of Trieste | Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Normobaric Hypoxia | NA | Status: NOT_YET_RECRUITING